Cellular distribution of human tissue kallikreins: immunohistochemical localization

被引:54
作者
Petralki, Constantina D.
Papanastasiou, Panagiotis A.
Karavana, Vassiliki N.
Diamandis, Eleftherios P. [1 ]
机构
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada
[3] Hygeia Hosp, Dept Urol, GR-15123 Athens, Greece
[4] Evangelismos Med Ctr, Dept Pathol, GR-10676 Athens, Greece
关键词
cancer biomarkers; human tissue kallikreins; immunohistochemistry; prognostic markers; serine proteases;
D O I
10.1515/BC.2006.084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have studied the immunohistochemical expression (IE) of eight non-tissue-specific human kallikreins (hKs) (hK5, 6, 7, 10, 11, 12, 13, and 14) in different normal tissues. The IE was always cytoplasmic, showing a characteristic pattern in some tissues. Comparison of the IE of all hKs studied in the different tissues revealed no major differences, suggesting that they share a common mode of regulation. Furthermore, hKs were immunohistochemically revealed in a variety of tissues, indicating that no protein is tissue-specific (except for hK2 and hK3, which have tissue-restricted expression). In general, our results correspond well with data from RT-PCR and ELI-.SA assays. Glandular epithelia constitute the main kallikrein IE sites, and the staining in their secretions confirms that these proteases are secreted. A variety of other tissues express the proteins as well. We have also immunohistochemically evaluated all the above hKs in several malignant tissues. Tumors arising from tissues expressing kallikreins tested positive. Corresponding to the IE in normal glandular tissues, most hKs were expressed in adenocarcinomas. The prognostic value of several hKs was studied in series of prostate, renal cell, colon and urothelial carcinomas.
引用
收藏
页码:653 / 663
页数:11
相关论文
共 107 条
  • [1] IMMUNOHISTOCHEMICAL DISTRIBUTION OF THE 3 PREDOMINANT SECRETORY PROTEINS IN THE PARENCHYMA OF HYPERPLASTIC AND NEOPLASTIC PROSTATE-GLANDS
    ABRAHAMSSON, PA
    LILJA, H
    FALKMER, S
    WADSTROM, LB
    [J]. PROSTATE, 1988, 12 (01) : 39 - 46
  • [2] Kallikrein and kinin receptor expression in inflammation and cancer
    Bhoola, K
    Ramsaroop, R
    Plendl, J
    Cassim, B
    Dlamini, Z
    Naicker, S
    [J]. BIOLOGICAL CHEMISTRY, 2001, 382 (01) : 77 - 89
  • [3] BHOOLA KD, 1992, PHARMACOL REV, V44, P1
  • [4] The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast
    Black, MH
    Diamandis, EP
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2000, 59 (01) : 1 - 14
  • [5] Black MH, 2000, BRIT J CANCER, V82, P361
  • [6] The emerging roles of human tissue kallikreins in cancer
    Borgoño, CA
    Diamandis, EP
    [J]. NATURE REVIEWS CANCER, 2004, 4 (11) : 876 - 890
  • [7] The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer
    Cane, S
    Bignotti, E
    Bellone, S
    Palmieri, M
    De las Casas, L
    Roman, JJ
    Pecorelli, S
    Cannon, MJ
    O'Brien, T
    Santin, AD
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (01) : 60 - 66
  • [8] Chang A, 2001, ANTICANCER RES, V21, P3147
  • [9] Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer
    Chang, A
    Yousef, GM
    Scorilas, A
    Grass, L
    Sismondi, P
    Ponzone, R
    Diamandis, EP
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (09) : 1457 - 1464
  • [10] KALLIKREIN CONTENT OF RAT PANCREATIC ACINAR-CELLS OR ISLETS BY DIRECT RADIOIMMUNOASSAY
    CHAO, J
    SOSTEK, M
    SHIMAMOTO, K
    BANK, HL
    BIGELOW, J
    MARGOLIUS, HS
    [J]. HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1980, 361 (12): : 1805 - 1810